Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ)
000403.SZ Stock Price Chart
Explore Pacific Shuanglin Bio-pharmacy Co., Ltd. interactive price chart. Choose custom timeframes to analyze 000403.SZ price movements and trends.
000403.SZ Company Profile
Discover essential business fundamentals and corporate details for Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Feb 2013
Employees
2.64K
Website
https://www.slbiop.comCEO
Xiankui Rong
Description
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.
000403.SZ Financial Timeline
Browse a chronological timeline of Pacific Shuanglin Bio-pharmacy Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 22 Aug 2025
EPS came in at ¥0.15 falling short of the estimated ¥0.25 by -40.00%.
Dividend declared on 4 Jun 2025
A dividend of ¥0.27 per share was announced, adjusted to ¥0.27. The dividend was paid on 4 Jun 2025.
Earnings released on 23 Apr 2025
EPS came in at ¥0.28 falling short of the estimated ¥0.32 by -12.50%, while revenue for the quarter reached ¥764.42M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.12 , while revenue for the quarter reached ¥374.65M .
Dividend declared on 17 Dec 2024
A dividend of ¥0.20 per share was announced, adjusted to ¥0.15. The dividend was paid on 17 Dec 2024.
Earnings released on 27 Oct 2024
EPS came in at ¥0.30 surpassing the estimated ¥0.29 by +3.45%, while revenue for the quarter reached ¥754.09M .
Earnings released on 27 Aug 2024
EPS came in at ¥0.28 surpassing the estimated ¥0.25 by +12.00%, while revenue for the quarter reached ¥695.61M .
Dividend declared on 28 Jun 2024
A dividend of ¥0.26 per share was announced, adjusted to ¥0.20. The dividend was paid on 28 Jun 2024.
Earnings released on 26 Apr 2024
EPS came in at ¥0.17 , while revenue for the quarter reached ¥435.64M , missing expectations by -9.81%.
Earnings released on 27 Mar 2024
EPS came in at ¥0.39 , while revenue for the quarter reached ¥953.91M .
Earnings released on 30 Oct 2023
EPS came in at ¥0.25 , while revenue for the quarter reached ¥665.74M .
Earnings released on 24 Aug 2023
EPS came in at ¥0.12 , while revenue for the quarter reached ¥448.21M .
Dividend declared on 20 Jul 2023
A dividend of ¥0.10 per share was announced, adjusted to ¥0.08. The dividend was paid on 20 Jul 2023.
Earnings released on 29 Apr 2023
EPS came in at ¥0.32 , while revenue for the quarter reached ¥911.72M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.08 , while revenue for the quarter reached ¥260.86M .
Earnings released on 30 Oct 2022
EPS came in at ¥0.18 , while revenue for the quarter reached ¥502.42M .
Earnings released on 30 Aug 2022
EPS came in at ¥0.16 , while revenue for the quarter reached ¥490.63M .
Dividend declared on 15 Jul 2022
A dividend of ¥0.06 per share was announced, adjusted to ¥0.06. The dividend was paid on 15 Jul 2022.
Earnings released on 30 Apr 2022
EPS came in at ¥0.14 falling short of the estimated ¥0.32 by -56.25%, while revenue for the quarter reached ¥500.42M .
Earnings released on 15 Apr 2022
EPS came in at ¥0.12 , while revenue for the quarter reached ¥629.53M .
Earnings released on 19 Oct 2021
EPS came in at ¥0.18 , while revenue for the quarter reached ¥551.58M .
Earnings released on 27 Aug 2021
EPS came in at ¥0.16 , while revenue for the quarter reached ¥505.77M .
Earnings released on 29 Apr 2021
EPS came in at ¥0.09 , while revenue for the quarter reached ¥284.86M .
Earnings released on 24 Mar 2021
EPS came in at ¥0.17 , while revenue for the quarter reached ¥387.81M .
Earnings released on 25 Oct 2020
EPS came in at ¥0.08 , while revenue for the quarter reached ¥235.00M .
000403.SZ Stock Performance
Access detailed 000403.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.